{"summary":"* ExFDA CMC Application Technical Lead for biologic products.  Product portfolio includes monoclonal antibodies, bispecifics, antibody drug conjugates, fusion proteins, radiolabelled proteins, cytokines and growth factors; specialized in both innovator biologic and biosimilar products.\n* Expert in product immunogenicity risk assessment and immunogenicity assay development and validation. \n* Invited speaker and panelist in national meetings as representative of the Agency.\n* Co-author of multiple research and white papers on areas of emerging technology and bioanalysis.","lastName":"Yan","objectUrn":"urn:li:member:85497341","geoRegion":"Bethesda, Maryland, United States","fullName":"Haoheng (Sandy) Yan","firstName":"Haoheng (Sandy)","currentPositions":[{"companyName":"Hengenix Biotech, Inc.","title":"Head of US Regulatory Affairs","tenureAtCompany":{"numYears":2,"numMonths":5},"companyUrnResolutionResult":{"employeeCountRange":"51-200","headquarters":{"geographicArea":"California","country":"United States","city":"Milpitas","postalCode":"95035","line1":"430 N McCarthy Blvd"},"website":"https:\/\/henlius.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/hengenix-biotech\/","industry":"Biotechnology Research"},"startedOn":{"month":1,"year":2022},"companyUrn":"urn:li:fs_salesCompany:19175051"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAUYlf0BNGBnTHczWTquhosazNPkYFz5PQ8,NAME_SEARCH,hrF4)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1652162249739?e=1723075200&v=beta&t=ujZol3oSJoZisVOn_FMR5KA0A75oZxos2UQhO_y4t1Q","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1652162249739?e=1723075200&v=beta&t=CkLTjgAu4OohPfWqTKoTPjLyXfL67qXT0A9wE0AZ1d4","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1652162249739?e=1723075200&v=beta&t=mcVxuTt_DEycJAeFT6BS2ZaC5K9sdfQHuk8hCM3YwI0","height":400},{"width":426,"fileIdentifyingUrlPathSegment":"800_800\/0\/1652162249739?e=1723075200&v=beta&t=80AGlDijHywKUTiBaYiy5ZlrH-koPrxMb6vuu8CSbf4","height":426}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C5603AQEBpPyUmMNvmA\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2009},"degree":"Ph.D","eduId":60640704,"schoolUrn":"urn:li:fs_salesSchool:4508","school":"urn:li:fs_salesSchool:4508","fieldsOfStudy":["Molecular and Cellular Biology"],"schoolName":"University of Massachusetts, Amherst","startedOn":{"year":2003}},{"endedOn":{"year":2002},"degree":"M.D.","eduId":60640797,"schoolUrn":"urn:li:fs_salesSchool:3556405","school":"urn:li:fs_salesSchool:3556405","fieldsOfStudy":["Clinical Medicine"],"schoolName":"Peking Union Medical College","startedOn":{"year":1997}},{"endedOn":{"year":1997},"eduId":60640823,"schoolUrn":"urn:li:fs_salesSchool:20289","school":"urn:li:fs_salesSchool:20289","fieldsOfStudy":["Premed Program"],"schoolName":"Peking University","startedOn":{"year":1994}},{"endedOn":{"year":1994},"schoolName":"\u4e0a\u6d77\u5e02\u683c\u81f4\u4e2d\u5b66","startedOn":{"year":1988},"eduId":141709031}],"skills":[{"numOfEndorsement":1,"name":"Immunogenicity"},{"numOfEndorsement":1,"name":"CMC Regulatory Affairs"},{"numOfEndorsement":6,"name":"Assay Development"},{"numOfEndorsement":4,"name":"qPCR"},{"numOfEndorsement":1,"name":"ELISA"},{"numOfEndorsement":1,"name":"Biochemistry"},{"numOfEndorsement":1,"name":"Life Sciences"},{"numOfEndorsement":0,"name":"Animal Models"},{"numOfEndorsement":0,"name":"Molecular Cloning"},{"numOfEndorsement":0,"name":"Immunohistochemistry"},{"numOfEndorsement":0,"name":"Pathology"},{"numOfEndorsement":0,"name":"Confocal Microscopy"},{"numOfEndorsement":0,"name":"Regulatory Affairs"},{"numOfEndorsement":0,"name":"Cancer Cell Biology"},{"numOfEndorsement":0,"name":"digital PCR"},{"numOfEndorsement":0,"name":"Biosimilars"}],"numOfConnections":1169,"patents":[],"headline":"Regulatory Affairs Executive, ExFDA Biologics Team Leader","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/haohengyan","organizations":[],"location":"Bethesda, Maryland, United States","publications":[{"name":"Multi-Attribute Method for Quality Control of Therapeutic Proteins","publishedOn":{"month":10,"day":16,"year":2019},"publisher":"Anal. Chem. 2019, 91, 14170\u201314177","url":"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acs.analchem.9b03808","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAUYlf0BNGBnTHczWTquhosazNPkYFz5PQ8,NAME_SEARCH,hrF4)"}]},{"name":"Ado-Trastuzumab Emtansine Targets Hepatocytes Via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity.","publishedOn":{"month":3,"day":1,"year":2016},"publisher":"Mol Cancer Ther 2016 Mar;15(3):480-90","url":"https:\/\/mct.aacrjournals.org\/content\/15\/3\/480","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAUYlf0BNGBnTHczWTquhosazNPkYFz5PQ8,NAME_SEARCH,hrF4)"}]},{"name":"2020 White Paper in Bioanalysis","publishedOn":{"month":6,"day":1,"year":2020},"publisher":"Bioanalysis Journal (Future Science, UK)","url":"https:\/\/www.future-science.com\/doi\/pdf\/10.4155\/bio-2021-0005","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAUYlf0BNGBnTHczWTquhosazNPkYFz5PQ8,NAME_SEARCH,hrF4)"}]},{"name":"2019 White Paper in Bioanalysis, Biomarkers, Immunogenicity and Gene Therapy","publishedOn":{"month":4,"day":1,"year":2019},"publisher":"Bioanalysis Journal (Future Science, UK)","url":"https:\/\/www.future-science.com\/doi\/pdf\/10.4155\/bio-2019-0271","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAUYlf0BNGBnTHczWTquhosazNPkYFz5PQ8,NAME_SEARCH,hrF4)"}]}],"positions":null,"posts":[{"createdAt":1713890460000,"insightId":"3d4c308b-0e7b-4c4e-8812-06c338deed23","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7188549540222750721,7188577689836888064)","threadUrn":"urn:li:ugcPost:7188549540222750721","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations, Anindya! All the best in your new adventure!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7188549540222750721"}}},{"createdAt":1712409420000,"insightId":"4fa2b17b-8e55-41b8-8225-339499f7b7cb","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7182359635411054592,7182365867920216064)","threadUrn":"urn:li:ugcPost:7182359635411054592","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7182359635411054592"}}}]}